The objectives of the campaign are to raise awareness about glaucoma, its risk factors, and the importance of regular eye check-up
First patient enrolled in the Phase III SOHO-02 trial of investigational agent BAY 2927088 in treatment-naïve patients with advanced NSCLC with HER2-activating mutations
The new bioeconomy policy rolled out by the Modi government is set to place India as a global leader in the years to come
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India
The drug will be marketed in different strengths of 150 mg and 440 mg and used in the treatment of patients with HER2
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Further strengthens BaseLaunch's global pharma industry partnerships
NULIBRY is a first-in-class synthetic cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A
Around 7% of the Indian population suffers from IBS
Subscribe To Our Newsletter & Stay Updated
